$2.6 billion, global contract research organization (CRO) ICON’s CIO Tom O’Leary believes telemedicine, wearables and AI could boost clinical-trial participation reports Jessica Twentyman of Diginomica. Based in Dublin, ICON is one of the top 10 CROs worldwide. Known to be tech-savvy, they have made multiple acquisitions including the FireCrest investigator training portal some years ago. FireCrest was exceptional—founded by physicians they knew how to design protocol and therapeutic area trial training and distribute via portal technology. It helped sites.
As part of a turkey service provider to industry sponsors, CROs must deliver the goods—including patients—as part of their clinical trials outsourcing execution services. Patient recruitment represents an enduring challenges for reasons TrialSite News has covered many times. As noted in our blog, our founding principal spent an intensive couple years working to solve patient recruitment problems nearly two decades ago—many of the same problems persist today!
A lack of diversity represents an profound and perplexing problem for industry. Industry must find ways to cross economic, ethnic, cultural and social barriers to engage with a vast cross reference of society. The health care challenges merit action now.
Per the article, ICON runs clinical trials with between 70,000 and 100,000 participants at any given point in time. O’Leary notes to Ms. Twentyman that the CRO constantly seeks to improve efficiency and effectiveness including patient participation. O’Leary believes that technology offers compelling ways to consider improving engagement. Virtual trials offer ways to include others that couldn’t participate before—and telemedicine is a core underpinning for virtual trials. O’Leary goes on to describe some trends with how telemedicine, wearables and AI can help support greater subject participation.
Follow the link to read the Diginomica article.